Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Oral Medications for Treating Agitation in a Safety Net Emergency Department

In this quality improvement study, emergency physicians successfully adopted oral medications for treating agitation, primarily from intoxication.


Question Can emergency physicians adopt using oral medications as first-line treatment for agitation primarily from intoxication?

Findings In this quality improvement study evaluating 460 600 ED encounters, the proportion of patients receiving their first sedating medication orally increased from 7% to 31% after 1 year of the intervention, while time to adequate sedation and adverse events, measured prospectively during implementation, were not different between oral and intramuscular routes.

Use of Flexion-Extension MRI to Reveal Occult Spondylotic Compression in Undifferentiated Cervical Myelopathies With Cord T2 Hyperintensity

Background and ObjectivesIn cervical spondylotic myelopathy (CSM), compression may not be evident in the neutral position, potentially leading to misdiagnosis and delayed treatment. We sought to assess the utility of flexion-extension MRI in revealing…

2025 FDA approvals

Lots of interesting information! The Zevaskyn (“a first cell-sheet-based gene therapy”) approval for treating epidermolysis bullosa (EB) is particularly uplifting. Back in high school, I knew someone with EB. It is a devastating disease. On the less happy side, an AAV9 therapy and an oncolytic virus therapy were rejected this year. [ https://www.nature.com/articles/d41573-026-00001-z](https://www.nature.com/articles/d41573-026-00001-z)


The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.

/* */